Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#3 most reported symptom for this vaccine
Injection site warmth has been reported 5 times in association with DT + IPV vaccination in VAERS. This represents 14.7% of all 34 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 0 involved hospitalization (0.0%).
Injection site warmth is the #3 most frequently reported symptom for DT + IPV out of 14 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 5 reports of Injection site warmth after DT + IPV vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.